Danaher and Sybron Dental Specialties Settle Shareholder Litigation
06 5월 2006 - 1:51PM
PR Newswire (US)
WASHINGTON and NEWPORT BEACH, Calif., May 5 /PRNewswire-FirstCall/
-- Danaher Corporation (NYSE:DHR) and Sybron Dental Specialties,
Inc. (NYSE:SYD) jointly announced today that an agreement in
principle has been reached to settle a class action law suit filed
on April 24, 2006 by Dolphin Limited Partnership I, L.P. and other
parties, in the Superior Court of the State of California, Orange
County. Danaher's tender offer to purchase any and all of Sybron's
outstanding common stock is scheduled to expire at 12:00 midnight,
Eastern Daylight Time, on Monday, May 15, 2006, unless otherwise
extended. The offer remains subject to customary conditions,
including tender of a majority of the outstanding shares into the
offer, and the absence of a material adverse effect with respect to
Sybron. The settlement resolves allegations by the plaintiffs
against Danaher, Sybron and Sybron's directors, in connection with
the tender offer, and includes no admission of wrongdoing. Under
the terms of the settlement, the parties have agreed to reduce the
termination fees associated with the transaction to an aggregate
amount of $45 million in fees and expenses. In addition, the
parties have agreed that Sybron's shareholders rights plan and
certain other contractual restrictions will not apply to tender
offers by third parties who offer Sybron's shareholders above $47
in cash, sign and deliver the same merger agreement that Danaher
signed and comply with certain other conditions. While the
provisions of the agreement in principle referred to in this
paragraph are effective immediately, certain other provisions of
the settlement are, as is customary, subject to court approval. The
full terms of the settlement in principle will be filed with the
Securities and Exchange Commission by Danaher on an amendment to
its Form TO and by Sybron on an amendment to its Schedule 14D-9.
Danaher Corporation is a leading manufacturer of Professional
Instrumentation, Industrial Technologies, and Tools and Components.
(http://www.danaher.com/) Sybron Dental Specialties and its
subsidiaries are leading manufacturers of both a broad range of
value-added products for the dental profession, including the
specialty markets of orthodontics, endodontics and implantology,
and a variety of infection prevention products for use by the
medical profession. (http://www.sybrondental.com/) Securityholders
of Sybron Dental are urged to read the tender offer statement,
letter of transmittal and other materials relating to the tender
offer, as they contain important information, including the various
terms of, and conditions to, the tender offer. Securityholders can
obtain a copy of the tender offer statement, letter of transmittal
and other related materials free of charge from the SEC's Edgar
Database, which can be accessed through the SEC's Internet site
(http://www.sec.gov/), or from the information agent for the tender
offer, MacKenzie Partners, Inc., by calling (800) 322-2885 (call
toll-free). We urge Sybron Dental securityholders to carefully read
those materials prior to making any decision with respect to the
tender offer. Statements about the expected effects, timing and
completion of the proposed transaction and all other statements in
this release other than historical facts, constitute
forward-looking statements. Forward-looking statements can be
identified by contain words such as "believes," "expects," "may,"
"will," "would," "should," "seeks," "approximately," "intends,"
"plans," "estimates," or "anticipates" or similar expressions which
concern future strategies, plans or intentions. These statements
are based on current expectations and involve risks and
uncertainties relating to, among other things, whether the
conditions to the tender offer will be satisfied, general economic
factors, business and capital market conditions, general industry
trends, changes in tax law requirements and government regulation.
Sybron and Danaher wish to caution the reader that these factors
are among the factors that could cause actual results to differ
materially from the expectations described in the forward looking
statements. DATASOURCE: Danaher Corporation CONTACT: Andy Wilson,
Vice President, Investor Relations of Danaher Corporation,
+1-202-828-0850, or Fax: +1-202-828-0860 Web site:
http://www.danaher.com/ http://www.sybrondental.com/
Copyright
Sybron Dental (NYSE:SYD)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
Sybron Dental (NYSE:SYD)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025